Johnson & Johnson, US4781601046

Johnson & Johnson stock gains 1.02% to EUR 244.48 premarket

Published on 11/20/2026 at 07:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Johnson & Johnson develops healthcare solutions for complex diseases and less invasive treatment. On Xetra, the stock closed at EUR 242.00 on Thursday, November 19, 2026.

Johnson & Johnson At A Glance

  • Johnson & Johnson focuses on healthcare innovation, including treatments for complex diseases and less invasive solutions.
  • The company says more than 75% of sales come from products holding a number-one or number-two global market-share position.
  • Johnson & Johnson reports more than 60 consecutive years of dividend increases.
Johnson & Johnson, US4781601046, Illustration mit AI erstellt.

Johnson & Johnson stock traded at EUR 244.48 on Lang & Schwarz at 07:49 CET on Friday, November 20, 2026, 1.02% above the Xetra close of Thursday, November 19, at EUR 242.00.

Johnson & Johnson focuses on healthcare innovation spanning medicines, treatments and solutions for complex diseases. The company's investor relations site says more than 75% of sales come from products with a number-one or number-two global market-share position.

For broader market context, see the S&P 500.

More news and analyses on Johnson & Johnson stock.

Disclaimer...
en | US4781601046 | JOHNSON & JOHNSON | boerse | 70538852 | bgmi